TIMMARVA
Live / Applied — New application — not yet assigned to an examiner (as of 17 Sept 2026)
What this means for you
Not registered yet, but its 17 Sept 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50115076
- Mark type
- Stylized text
- Filed
- 17 Sept 2026
- Attorney of record
- Eric R. Moran
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; biologics; biosimilars; pegfilgrastim biosimilars; pharmaceutical preparations for the treatment of neutropenia; pharmaceutical preparations for the treatment of low white blood cells; pharmaceutical preparations for use in stimulating white blood cell production; biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production; recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable pegfilgrastim biosimilars; pharmaceutical preparations, namely, injectable biosimilars for the treatment of neutropenia; pharmaceutical preparations, namely, injectable biosimilars for the treatment of low white blood cells; pharmaceutical preparations, namely, injectable biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable recombinant-human granulocyte-CSF for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production; injectors sold filled with pegfilgrastim biosimilars; injectors sold filled with pharmaceutical preparations for the treatment of neutropenia; injectors sold filled with pharmaceutical preparations for the treatment of low white blood cells; injectors sold filled with pharmaceutical preparations for use in stimulating white blood cell production; injectors sold filled with biosimilars for use in stimulating white blood cell production; injectors sold filled with recombinant-human granulocyte-CSF for use in stimulating white blood cell production; injectors sold filled with recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production
- Class 042 — Scientific and technological services: Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to cancer and cancer treatments; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of cancer and cancer treatments
- Class 044 — Medical, beauty and agricultural services: Providing medical information; providing health information; providing medical information in the field of cancer and cancer treatments; providing health information in the field of cancer and cancer treatments; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services
Owner
- Hong Kong King-Friend, Industrial Company, Ltd., Hong Kong, HK
Prosecution history
- 17 Sept 2026 — APPLICATION FILING RECEIPT MAILED
- 17 Sept 2026 — NEW APPLICATION ENTERED